To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
The magnet of the future MRI at 11.7 teslas of the Iseult project at NeuroSpin (CEA Paris-Saclay) reached a magnetic field of 9.51 teslas during tests carried out on Wednesday 22 May. This new level is a record since the magnet has become on this occasion the most powerful MRI magnet in the world for imaging in humans with a stored energy of 221 MJ. This successful outcome is the result of the work of the Iseult project’s team from the CEA.
The French National Infrastructure of Integrated Structural Biology (FRISBI) is now integratinf Genopole's structural biology platform into its Paris-Sud node.
The M-CUBE consortium, funded by the H2020 program, is now listed in the "success stories" of the European Commission website. A further confirmation of the interest of the work of NeuroSpin physicits and their collaborators on metamaterials to "boost" the MRI of the future.
The union of the Saclay Plateau screening platforms under a single banner C @ PS (Criblage sur le Plateau de Saclay) has just obtained the IBiSA label. Jean-Christophe Cintrat (Joliot / SCBM) is in charge of the overall infrastructure.
Europe is committed to better diagnostic and therapeutic management of patients with severe forms of cirrhosis. It finances the MICROB-PREDICT consortium, which aims to better understand the role of the human microbiome in the pathogenesis and evolution of cirrhosis. Final goal is to uture personalized therapeutic strategies and diagnostic tools. The SPI (Joliot Institute) is the main project lead for the CEA.
On June 27, Stanislas Dehaene received an exceptional guest at NeuroSpin: the violinist Zhang Zhang and her band played together ZhangoMusic for an unprecedented evening, mixing music and brain, in front of a conquered public. The artist has enthusiastically lent herself to the different cognitive challenges proposed by Stanislas and his accomplices Laurent Cohen and Lionel Naccache.
The Neuro2Co project, led by INRA Val de Loire whose NeuroSpin is a partner, aims to test the hypothesis according to which the organization of brain connections, the connectome, accounts for behavioral adaptation strategies of different animal species. Under the impetus of this project, 3 science teachers from the secondary-school André Bauchant (37) animate since September 2017 a scientific workshop, the workshop Ciboulot, for students from 5th to 3rd. It is in this context that they came to NeuroSpin on June 12, hosted by Cyril Poupon and his team to achieve the acquisition of images in MRI of a quail brain.
Several teams from the Frédéric Joliot Institute took part in the sports event of the Paris-Saclay centre on June 22, 2018, a moment placed under the sign of conviviality and good humor. And some of them even won prizes ...
On the 7th and 8th of June were held the second edition of the PhD Days (JDD) of the Frédéric Joliot Institute for Life Sciences. In the spirit of previous days, PhD students and researchers met during four half-days to discuss about their work, but also to discover the diversity of topics addressed in our institute and expand their own knowledge.
A SIMOPRO project supported by SATT Paris-Saclay: in vivo validation of the efficacy of the DTR8 molecule, developed and patented at SIMOPRO (Department of Medicines and Technologies for Health) in collaboration with Inserm, as a treatment for glomerulonephritis rapidly progressive.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.